Member Info for dafad

Watching live on Bbc,what a load of codswallop,slides wtf

just tell us what your going to do about covid

Org30- I totally agree that it's worth millions but haven't we as a society been brainwashed by the big co's and their huge ad budgets to spend beyond our means?I have been taught from an early age that health is worth much more than materilistic possesions,a fundemental problem of the youth today is that they want to get all the big labels.cars etc etc without climbing the ladder from the bottom.Maybe if people talked more to their neighbours that would have a massive effect on mental health issues,surely it cannot be that hard to strike up converstion,I think schools have a big part to play and should promote much more life skills as opposed to academic results.Basic life skills such as talking,manners ,cooking ,will take you a very long way

So a month of lockdown for England,then everyone gets together over christmas and then back to square one.why are people so concerned abput christmas-surely peopleshould be able to have a low key christmas for one year in order to save long term

Sorry for the post,missed previous

particularly interesting at 59 min

also listen to whole interview from 36 min

https://www.youtube.com/watch?v=yAiNEGBqyzo

https://www.sciencemag.org/news/2020/10/very-very-bad-look-remdesivir-first-fda-approved-covid-19-drug

The 2,300m drill programme has initially focused on the Eclipse target within the licence, where a total of 1,710 metres has been drilled to date. The first assay results returned are for drillhole ECRC20_039, which intersected the main vein at Eclipse at approximately 85m from surface: 14m @ 2.57 g/t gold ('Au') from 94m downhole (using a 0.5 g/t Au cut-off), including 4m @ 4.98 g/t Au from 97m.

Clinigen Group plc (AIM: CLIN, "Clinigen" or the "Company"), announces that, on 27 October 2020, four Board directors and a person closely associated with a director acquired ordinary shares in the Group as follows:

Name, title

Number of shares purchased

Per Share Price

purchased

Aggregated total

Peter Allen, Chairman

5,000

609.00p

£30,450

Ian Nicholson, NED

2,000

603.52p

£12,070

Anne Hyland, NED

7,716

606.98p

£46,835

Alan Boyd, NED

7,000

607.24p

£42,507

Catherine Nicholson

1,000

600.97p

£6,010



The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

6/10/2020 7:00am
UK Regulatory (RNS & others)

EMPIRE METALS (AQSE:EEE.GB)
Intraday Stock Chart

Monday 26 October 2020

Click Here for more EMPIRE METALS Charts.
TIDMEEE

RNS Number : 1297D

Empire Metals Limited

26 October 2020

To view the announcement with the illustrative maps and diagrams please use the following link: http://www.rns-pdf.londonstockexchange.com/rns/1297D_1-2020-10-25.pdf

Empire Metals Limited / AIM: EEE / Sector: Natural Resources

26 October 2020

Empire Metals Limited ('Empire' or the 'Company')

Sale of Bolnisi Copper and Gold Project in Georgia for CAD 7 Million, Board and Management Changes

Empire Metals Limited, the AIM-listed mineral resource exploration and development company, is pleased to announce that it has concluded a definitive and binding Sale and Purchase Agreement (subject to certain conditions) for the sale of the Company's wholly-owned subsidiary GMC Investments Limited ('GMCIL'), to Candelaria Mining Corporation (TSXV: CAND) ('Candelaria', 'CAND' or the 'Buyer'), for an all-equity total consideration of 7 million Canadian dollars ("CAD"), with an initial payment of CAD 2 million (the 'Initial Consideration') plus additional payments subject to certain milestones being achieved in Georgia (altogether "the Sale"). GMCIL is the owner of a 50% interest in JSC Georgian Copper and Gold ('GCG'), which in turn holds the rights to copper-gold projects under a 30-year mining concession in Georgia.

Highlights

-- Sale of Georgian assets to TSXV listed company with an excellent track record of developing projects in complex jurisdictions

-- Initial consideration payment of CAD 2 million in shares of CAND
-- Three further payments in shares of CAND of CAD 1 million, CAD 2 million and CAD 2 million totalling CAD 5 million on achieving certain milestones

-- Mr. Mike Struthers to join CAND as CEO, but will remain as Non-Executive Director of Empire and act as a consultant to the Company

-- Dr Neil O'Brien, Non-Executive Chairman, to join the board of CAND as a Non-Executive Director but will remain as Non-Executive Chairman of Empire

-- Exposure to Candelaria's development projects in Mexico as well as continued exposure to growth in Georgia via an equity holding in CAND

-- Sale subject to a right-of-first-refusal ("ROFR") in favour of Empire's Georgian partners, Caucasian Mining Group ("CMG"), and also subject to shareholder approval.

Mike Struthers, CEO , said: "This is a great deal for Empire shareholders . Candelaria is a growth story with some excellent gold assets in Mexico, including the Pinos Gold Project which is about to start construction and is scheduled to commence production in 12-14 months. It has a strong technical and operations team on the ground in Mexico. Empire shareholders will benefit from the future production and growth of Candelaria, whilst retaining exposure to the assets in Georgia on which we will continue with our efforts to unlo

nm

Interesting from the newswires

https://uk.advfn.com/stock-market/stock-news/83526684/the-rockefeller-foundation-commits-usd1-billion-to

Increasing healthcare access to end the pandemic
Earlier this year, The Rockefeller Foundation, with support from an ideologically diverse team of top scientists, industry, technologists, and economists, launched a U.S. National Covid-19 Testing & Tracing Action Plan. It also collaborated with federal, state, and local leaders to increase access to Covid-19 testing, overall, with a particular focus on vulnerable communities all across America. Given the scale of the current crisis, the Foundation will continue to increase its investment in the U.S. and around the world to expand access to screening tests, treatments, and vaccines when they become available. Better data can identify communities at high risk for chronic and infectious disease and other health issues, directing resources to where they are needed most and targeting preventative interventions more precisely. Using predictive analytics, among other technologies, can better prevent a disease outbreak from becoming a pandemic.

"For too long, a person's health has been determined by who they are and where they live," said Dr. Naveen Rao, Senior Vice President of the Health Initiative at The Rockefeller Foundation. "We have an unprecedented opportunity to close the health inequity gap by driving innovation and investment to the most vulnerable communities around the world. This focus is our way of doubling down on our commitment to modernize public health and provide equitable health outcomes."

https://t.co/wyz0d0Uygo?amp=1

 Topol

@EricTopol

·

1h

Our differences in the interferon pathway, a 1st line of defense vs covid, are implicated in severe/critical cases: role of autoantibodies and genomic variants reviewed https://science.sciencemag.org/content/sci/370/6515/404.full.pdf…

@ScienceMagazine

w/

@ScienceVisuals

Talking on Welsh Radio about waste water in sewage, no mention of real time testing,but be worth keeping an eye out
on BANGOR University websites where trials are being run from.I did mention them a few months back

ri, 23rd Oct 2020 16:08

RNS Number : 1042D
Deepverge PLC
23 October 2020

23 October 2020

DeepVerge PLC

("DeepVerge" or "the Company")

Reach Announcement

Comment on media coverage of detection of COVID-19 in UK Sewage



DeepVerge notes press commentary today that wastewater treatment sites in England, Wales and Scotland will start testing more sewage for coronavirus, with the aim of creating an early warning system to detect local outbreaks before they spread.

DeepVerge has been working with multiple universities and wastewater utilities since June this year on COVID-19 related projects. The Company is involved in many projects in the U.K., Ireland, Italy, Michigan, US, Shanghai, China and Japan.

Currently, in its Labskin laboratories in York, the Company is retrofitting Microtox equipment, from Modern Water plc (a company currently the subject of a recommended offer by DeepVerge) to install these projects.

Gerard Brandon CEO of DeepVerge Commented:

"The UK forms part of our COVID-19 real-time detection development strategy, cooperating with Modern Water plc supply chain and existing installation network in more than 60 countries. We continue to work with our EcoSystemOS consortium partners in the UK and overseas to bring advanced AI-based wastewater detection and pathogen identification projects from manual to automated real-time testing."

For further information please contact:

Eric Topol
@EricTopol
How can Remdesivir get a full
@US_FDA
approval when there are such mixed data? Not supportive of this decision at all.
Does it work early? Does it work late? Does it work anytime?
So much unresolved.

Remdesivir, an antiviral drug originally developed to treat Ebola, has been approved for use on COVID-19 patients in the US.

The treatment, which is given through an IV in hospital, was signed off by the Food and Drug Administration (FDA).

Nearly 12 months since this interview with Dimitry,well worth a look to remind yourselves of what we have here and as Dimitry said 12 months ago-we are in no rush to sell

Https://www.youtube.com/watch?v=d_YMY6yiMDE

Cennin!!